Dec 2023: A collaborative study between the Roy and Hammond labs was published in JBC.

Dec 2023: Dr. David Gau presented a talk on kidney cancer at the annual ASCB/EMBO meeting.

Nov 2023: Abigail Allen-Gondringer successfully defended her Ph.D dissertation and will begin her post-doctoral fellowship at St. Jude’s Children’s Hospital beginning Jan 2024. Congratulations Dr. Allen-Gondringer!

September 2023: Aneri Shethji (high school student) submitted an abstract to BMES and received an honorable mention.

Vascular endothelial cell-specific disruption of the profilin1 gene leads to severe multiorgan pathology and inflammation causing mortality was published by PNAS Nexus.

August 2023: Jacob Antonello (graduate student) was selected as a Pitt Beview Fellow.

Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer was published by JBC.

July 2023: Andrew Orenberg (graduate student) receives a CBTP-T32 pre-doctoral fellowship

July 2023: Roy lab receives an NCI R01 grant (9/1/23-8/31/28) to study transcriptional regulation of dormancy and emergence in breast cancer

July 2023: Dr. Partha Roy will be appointed as an editorial board member of “Journal of Biological Chemistry” starting Jan 2024.

June 2023: Dr. Partha Roy is appointed as an editorial board member of “Cytoskeleton”.

May 2023: Dr. David Gau receives the Postdoctoral Alumni Award for his long-standing track record of representing various trainees at the University, including serving as the President of the University of Pittsburgh Postdoctoral Association (UPPDA) from 2019-2022.

May 2023: Ian Eder (graduate student) receives a CTSI-TL1 pre-doctoral fellowship

April 2023: Ian Eder (graduate student) receives an NSF honorable mention

April 2023: Virginia Yu (undergraduate student) receives a SURI fellowship for conducting summer research

March 2023: Niharika Welling (undergraduate researcher) receives a Brackenridge fellowship for conducting summer research

Dec 2022: Roy lab members presented at the Annual Meeting of ASCB/EMBO, Washington DC.

Abigail Allen: mini-symposium talk (session: Signaling and Cellular Plasticity) and poster

Dr. David Gau: micro-symposium talk (session: Cellular Microenvironment, building a niche) and poster

Ian Eder: micro-symposium talk (session: Cellular Microenvironment, building a niche) and poster

Andrew Orenberg, Pooja Chawla, and Virginia Yu: Posters

Oct 2022: Roy-Kolarcik research team receives a grant titled "Actin' against ALS" from the Clinical and Translational Science Institute of the University of Pittsburgh as part of the Pitt Innovation Challenge.

Aug 15, 2022: Dr. David Gau receives a NIH K99/R00 grant for his kidney cancer research

Aug 1, 2022: Ian Eder receives a NIH-T32 CATER pre-doctoral fellowship

May 1, 2022: Interdisciplinary team led by Dr. Partha Roy Receives an R21 grant from NIH for small molecule discovery research

Mar 02, 2022: Interdiscilinary team including Dr. Partha Roy receives $60k Pitt momentum teaming grant

Aug 15, 2021: Abigail Allen receives a NIH-F31 pre-doctoral fellowship for her cardiovascular research

Apr 09, 2021: Dr. Partha Roy received an NIH R01 and an award from the Magee Women's Cancer Research

May 21, 2021: Abigail Allen receives AHA Fellowship for her cardiovascular research

Nov 13, 2020: Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells manuscript was published by JBC

Oct 21, 2020: Roy Lab research featured in JBC special virtual issue

Sept 1, 2020: Dr. David Gau receives a NIH-T32 postdoctoral fellowship for his kidney cancer research

July 10, 2020: Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization manuscript was published by JBC

May 18, 2020: Dr. David Gau receives National Cancer Center Fellowship for Kidney Cancer Research